Jun 13, 2023 / 03:40PM GMT
Jamie Aaron Perse - Goldman Sachs Group, Inc., Research Division - Associate
Good morning, everyone. I'm Jamie Perse. Thank you for joining Day 2 of the Goldman Healthcare Conference. Our next panel is with Enovis. We have CEO, Matt Trerotola, CFO, Ben Berry; and in the audience, we've got IR, Derek Leckow. Thank you for joining.
Matthew L. Trerotola - Enovis Corporation - CEO & Chairman
Thank you. Great to be here. Thanks.
Questions and Answers:
Jamie Aaron Perse - Goldman Sachs Group, Inc., Research Division - AssociateMaybe we could start, I mean, I think investors are still getting up to speed on the company, and maybe you could just say a few words about the high-level story and where you guys are at today?
Matthew L. Trerotola - Enovis Corporation - CEO & Chairman
Yes, sure. Thanks. We're a focused med tech innovation-driven growth company, a little over $1.5 billion of revenues. We were created a little over a year ago by a separation from Colfax,